Enabling Awesome

Your partner in innovation

Enabling Awesome.

The journey from discovery to medical breakthrough demands imagination, speed, and focus. At Mission BioCapital, we provide early-stage capital to the next generation of awesome life science entrepreneurs and the platform where they can realize their visions. This approach has revolutionized the way life science start-ups progress from idea to key data through a model that champions collaboration at the center of everything we do.

Our team has a deep-rooted commitment to empowering exceptional life science entrepreneurs from all walks of life.

From your first experiment in our shared lab space through to the clinic, we want to be your partner in accelerating development of scientific solutions – faster, focused and more efficiently – to individuals and communities in most need.

We’re there, from idea to exit.

We are scientists, investors, founders, and serial entrepreneurs. Our team has a long history together, investing in, launching, and building dozens of early-stage life science companies.

Making Transformational Investments.

Founded in 2009, we are now investing out of our fifth fund. Since our inception, we have invested in early-stage life science companies following the same core principles:

News from Our Network

Follow us on twitter @MissionBioCap

Save the date for two big 2024 invite-only events this spring! Announcing the Tech Transfer Showcase with
@BioSPartners
(Feb 13), and another iteration of our hit BioLabs Investor Day series (April 16)

We’re very excited to have 16 NJ life science startups on the agenda for #biolabsinvestorday on Thursday! From pre-Seed to Series B, each company will get 5 minutes to give lightning pitches to a room full of other startups, investors, sponsors and partners.

Interested in pitching your biotech company to world-class investors? Join us for a packed day of curated networking and 5-minute pitches at BioLabs Investor Day on October 26! Pre-seed through Series B. Apply at http://wkf.ms/45MLTDn.